News BioNTech SE

Equities

BNTX

US09075V1026

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:01:04 2026-05-13 pm EDT			5-day change	1st Jan Change
92.18 ^USD	-1.58%		-3.21%	-3.15%

May. 12	Berenberg Lowers Price Target on BioNTech to $140 From $155, Keeps Buy Rating	MT
May. 12	BIONTECH : Receives a Buy rating from Berenberg	ZD

All News

Mentions Relevance

May. 12	Berenberg Lowers Price Target on BioNTech to $140 From $155, Keeps Buy Rating	MT
May. 12	BIONTECH : Receives a Buy rating from Berenberg	ZD
May. 07	BioNTech Approves $1 Billion ADS Repurchase Program	MT
May. 07	BioNTech Kicks off $1 Billion ADS Repurchase Plan	MT
May. 07	BioNTech Announces New ADS Repurchase Program	GL
May. 06	German government spokesperson: decision by Biontech regarding locations in Germany is business decision; we will not comment on the specifics	RE
May. 05	BioNTech Q1 Adjusted Loss Widens, Revenue Declines; Reaffirms 2026 Revenue Outlook	MT
May. 05	BioNTech Q1 Adjusted Loss Widens, Revenue Declines; Reaffirms 2026 Revenue Outlook	MT
May. 05	BioNTech: Though Q1 operations missed expectations, 2026 guidance remained unchanged
May. 05	BioNTech Q1 Adjusted Loss Widens, Revenue Declines; Reaffirms 2026 Revenue Outlook	MT
May. 05	BioNTech SE, Q1 2026 Earnings Call, May 05, 2026
May. 05	BioNTech SE Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
May. 05	BioNTech Q1 Adjusted Loss Widens, Revenue Declines; Reaffirms 2026 Revenue Outlook	MT
May. 05	BioNTech Mulls Sale of CureVac Sites, Operations in Germany, Singapore	MT
May. 05	BioNTech : BNTX 1Q 2026 Presentation	PU
May. 05	BioNTech : Q1 2026 Präsentation	PU
May. 05	BioNTech : BNTX Q1 2026 Exhibit 99.1 (Quarterly Report)	PU
May. 05	BioNTech : Q1 2026 Finanzbericht	PU
May. 05	BioNTech : BNTX 4QFY 2025 Presentation FINAL 200326 v2	PU
May. 05	(BNTX) BioNTech Expects 2026 Revenue Range 2B Euros - 2.3B Euros, vs. FactSet Est of 2.22B Euros	MT
May. 05	Earnings Flash (BNTX) BioNTech Posts Q1 Revenue 118.1M Euros, vs. FactSet Est of 164.6M Euros	MT
May. 05	Earnings Flash (BNTX) BioNTech Posts Q1 Adjusted Loss 1.95 Euros a Share	MT
May. 05	BioNTech to exit operations at CureVac's sites, sites in Idar-Oberstein, Marburg, Singapore	RE
May. 05	BioNTech SE announces an Equity Buyback for $1,000 million worth of its shares.	CI
May. 05	BioNTech Announces First Quarter 2026 Financial Results and Corporate Update	GL